1. Home
  2. LSTA vs SPCB Comparison

LSTA vs SPCB Comparison

Compare LSTA & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • SPCB
  • Stock Information
  • Founded
  • LSTA 1980
  • SPCB 1988
  • Country
  • LSTA United States
  • SPCB Israel
  • Employees
  • LSTA N/A
  • SPCB N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • SPCB Semiconductors
  • Sector
  • LSTA Health Care
  • SPCB Technology
  • Exchange
  • LSTA Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • LSTA 22.5M
  • SPCB 53.3M
  • IPO Year
  • LSTA N/A
  • SPCB N/A
  • Fundamental
  • Price
  • LSTA $2.72
  • SPCB $10.70
  • Analyst Decision
  • LSTA Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • LSTA 1
  • SPCB 1
  • Target Price
  • LSTA $15.00
  • SPCB $18.00
  • AVG Volume (30 Days)
  • LSTA 23.5K
  • SPCB 133.1K
  • Earning Date
  • LSTA 08-11-2025
  • SPCB 08-14-2025
  • Dividend Yield
  • LSTA N/A
  • SPCB N/A
  • EPS Growth
  • LSTA N/A
  • SPCB N/A
  • EPS
  • LSTA N/A
  • SPCB 1.89
  • Revenue
  • LSTA $1,000,000.00
  • SPCB $27,831,000.00
  • Revenue This Year
  • LSTA N/A
  • SPCB $2.73
  • Revenue Next Year
  • LSTA N/A
  • SPCB $22.87
  • P/E Ratio
  • LSTA N/A
  • SPCB $5.56
  • Revenue Growth
  • LSTA N/A
  • SPCB 2.90
  • 52 Week Low
  • LSTA $1.87
  • SPCB $2.55
  • 52 Week High
  • LSTA $4.20
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 52.43
  • SPCB 55.03
  • Support Level
  • LSTA $2.34
  • SPCB $9.23
  • Resistance Level
  • LSTA $3.09
  • SPCB $10.97
  • Average True Range (ATR)
  • LSTA 0.25
  • SPCB 0.61
  • MACD
  • LSTA 0.01
  • SPCB -0.11
  • Stochastic Oscillator
  • LSTA 50.67
  • SPCB 65.97

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: